The U.S. Food and Drug Administration announced on Friday an upcoming public meeting, scheduled for next month, which will deal with the safety issues raised by a chemical discovered in baby bottles and several other similar products.

The chemical, bisphenol A or BPA, is known for affecting children and animals and as soon as the discovery was made public, people demanded immediate action. In response, the FDA, backed-up by the European regulators, explained that the chemical does not present any risks and that it is completely safe.

The information about the chemical was provided by the National Toxicology Program, which is part of the U.S. government's National Institutes of Health. The agency’s researchers believe that bisphenol A represents a great danger for fetuses, infants and children, as it might cause neural and behavioral problems. Apparently, the BPA tampers with the body’s estrogen absorption, which is one of the key components needed in the healthy development of young bodies.

A study released by the Center for Disease Control and Prevention signaled that an alarming 93 percent of all Americans have bisphenol A detected in their urine. The FDA responded, saying that the chemical’s levels are thousands of times lower than the ones considered dangerous.

Looking to assure people that the situation is blown out of proportions, the FDA released a draft report saying that "Safe or safety means that there is reasonable certainty in the minds of competent scientists that the substance is not harmful under the intended conditions of use," but "complete certainty of absolute harmlessness is scientifically impossible to establish."